Form 4: Cingulate Inc. Director Granted Stock Options, Aligning Interests with Shareholders

Cingulate Inc. Director Lawrence Bryan Jay has been granted 15,000 stock options, aligning his interests with the company's future performance.

Summary

• Lawrence Bryan Jay, a Director of Cingulate Inc. (CING), was granted 15,000 stock options.
• The transaction date for the option grant was June 20, 2025.
• Each stock option has an exercise price of $4.14.
• The options will vest on the earlier of (i) the one-year anniversary of the grant date (June 20, 2026) or (ii) the date of Cingulate Inc.'s 2026 annual meeting of stockholders.
• The expiration date for these stock options is June 20, 2035.
• Following this transaction, Mr. Jay beneficially owns 15,000 derivative securities (stock options) directly.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as the option grant aligns the director's interests with shareholders, but it's a routine compensation event and not indicative of major operational or financial news.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options' value increases with the company's stock price.
• The exercise price of $4.14 per share indicates a future target for stock performance for the options to be in-the-money.

Future Outlook

The document primarily reports a past transaction and does not provide explicit forward-looking statements or guidance beyond the vesting schedule of the granted options.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity grant to a director, which is a common practice across industries to incentivize and align management with shareholder interests. It does not provide information on broader industry trends or competitive positioning.

Related Party Transactions

• The grant of 15,000 stock options to Director Lawrence Bryan Jay by Cingulate Inc. constitutes a related party transaction, as it involves a transaction between the company and a member of its board of directors.

Stakeholder Impact

• Shareholders: The option grant can be viewed positively as it aligns the director's financial incentives with the company's stock performance, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The stock options will vest on the earlier of June 20, 2026, or the date of the Cingulate Inc. 2026 annual meeting of stockholders.
• Following vesting, the director may choose to exercise the options at the stated exercise price before the expiration date.

Key Dates

Keywords

Cingulate Inc., CING, Stock Options, Director Compensation, Insider Transaction, SEC Form 4, Beneficial Ownership, Equity Grant